Informação da revista
Vol. 41. Núm. 5.
Páginas 441-443 (maio 2022)
Partilhar
Partilhar
Baixar PDF
Mais opções do artigo
Vol. 41. Núm. 5.
Páginas 441-443 (maio 2022)
Letter to the Editor
Open Access
Left ventricular deformation in hemophilia (from the MAGYAR-Path Study)
Deformação miocárdica ventricular esquerda na hemofilia (do estudo MAGYAR-Path)
Visitas
2271
Attila Nemesa,
Autor para correspondência
nemes.attila@med.u-szeged.hu

Corresponding author.
, Árpád Kormányosa, Klára Vezendib,c, Imelda Martonb,c, Zita Borbényib
a Department of Medicine, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary
b Division of Haematology, Department of Medicine, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary
c Department of Transfusiology, Medical Faculty, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (1)
Tabelas (2)
Table 1. Two-dimensional echocardiographic data of hemophilia patients and controls.
Table 2. Comparison of three-dimensional speckle-tracking echocardiography-derived global and mean segmental left ventricular peak strains between hemophilia patients and controls.
Mostrar maisMostrar menos
Texto Completo

Hemophilia is the most common severe coagulation disorder (deficiency of factor VIII causing type A and deficiency of factor IX causing type B).1 Hemophilia-related changes in left ventricular (LV) function have been little examined. Three-dimensional (3D) speckle-tracking echocardiography (3DSTE) can provide detailed assessment of LV contractility represented by LV strains.2,3 The present study was designed to compare 3DSTE-derived LV strains between patients with hemophilia and matched controls.

The study analyzed 16 male patients with hemophilia, three of whom were excluded due to insufficient image quality. Eleven patients had hemophilia A, while two had hemophilia B. Mean age was 42.1±19.5 years. Hypertension, hypercholesterolemia, diabetes mellitus, HCV positivity and hemophilic arthropathy were present in five, three, two, nine and eight patients, respectively. All patients were treated with a 1000-6000 U/week dose of factors for each patient. Their results were compared to those of 15 healthy male controls with a mean age of 46.3±6.0 years.

Complete two-dimensional Doppler echocardiography (2DDE) and 3DSTE were performed in all hemophilia patients and controls. Results are from the MAGYAR-Path (Motion Analysis of the heart and Great vessels bY three-dimensionAl speckle-tRacking echocardiography in Pathological cases) Study.2 The institutional ethics committee at the University of Szeged approved the study, which complied with the 1975 Declaration of Helsinki (and updated versions) and all hemophilia patients and controls gave informed consent.

2DDE and 3DSTE were performed on a Toshiba Artida cardiac ultrasound system using a broadband 1-5 MHz PST-30SBP phased array transducer and a PST-25SX matrix array transducer (Toshiba Medical Systems, Tokyo, Japan), respectively. 2DDE-derived chamber quantifications and Doppler assessments were performed according to the guidelines.2,3 3DSTE was performed according to recent practice with offline analysis by 3D Wall Motion Tracking software as detailed previously. Global, mean segmental and regional LV strains in longitudinal (LS), circumferential (CS) and radial (RS) directions were calculated. Combined strains (area strain, AS, and 3D strain, 3DS) were also measured (Figure 1).3,4

Figure 1.

Images from three-dimensional (3D) speckle-tracking echocardiographic analysis in apical 4-chamber view (A), apical 2-chamber view (B) and apical (C3), mid-ventricular (C5) and basal (C7) left ventricular (LV) short-axis views together with a 3D virtual model of the LV (red D), LV volumetric data on the cardiac cycle (red E) and time – LV segmental and global strain curves (colored lines) with a time – LV volume changes curve (dashed line) during the cardiac cycle (red F). LA: left atrium; LV: left ventricle; RA: right atrium; RV: right ventricle.

(0.43MB).

2DDE data did not differ between hemophilia patients and controls (Table 1). Doppler echocardiography did not identify grade ≥1 valvular regurgitation or valvular stenosis in any patients or controls. 3DSTE-derived global and mean segmental LV strains did not show differences between groups, while only regional basal and midventricular LV circumferential strains (CSs) were significantly reduced in patients with hemophilia compared to healthy controls (Table 2).

Table 1.

Two-dimensional echocardiographic data of hemophilia patients and controls.

  Controls (n=15)  Hemophilia patients (n=13) 
LA diameter, mm  40.0±4.1  38.6±3.5  0.3 
LV end-diastolic diameter, mm  47.9±3.4  50.4±3.3  0.04 
LV end-diastolic volume, ml  108.0±20.2  122.3±18.9  0.06 
LV end-systolic diameter, mm  32.2±2.6  31.8±3.1  0.6 
LV end-systolic volume, ml  38.4±7.2  40.8±9.8  0.4 
Interventricular septum, mm  9.6±1.2  9.9±1.1  0.3 
LV posterior wall, mm  9.4±1.1  9.8±1.1  0.4 
E, cm/s  71.8±19.2  74.1±13.6  0.7 
A, cm/s  62.1±15.5  65.6±13.4  0.5 
E/A  1.20±0.35  1.08±0.28  0.3 
LV ejection fraction, %  64.5±3.2  66.9±4.0  0.08 

A: transmitral late diastolic inflow velocity; E: transmitral early diastolic inflow velocity; LA: left atrial, LV: left ventricular.

Table 2.

Comparison of three-dimensional speckle-tracking echocardiography-derived global and mean segmental left ventricular peak strains between hemophilia patients and controls.

  Controls (n=15)  Hemophilia patients (n=13) 
Global strains
RS, %  25.5±10.4  21.2±9.9 
CS, %  -25.8±3.3  -23.8±4.1 
LS, %  -15.6±2.3  -15.8±3.4 
3DS, %  28.1±10.0  24.6±9.0 
AS, %  -38.3±3.3  -36.9±4.9 
Mean segmental strains
RS, %  28.0±10.0  23.9±10.3 
CS, %  -27.0±3.4  -25.6±3.9 
LS, %  -16.5±2.1  -14.6±4.9 
3DS, %  30.3±9.4  25.5±10.6 
AS, %  -39.4±3.1  -38.2±5.0 
Regional strains
RS basal, %  33.8±14.0  30.5±13.1 
RS mid, %  31.0±12.8  26.6±11.3 
RS apex, %  14.8±5.7  16.5±12.1 
CS basal, %  -26.2±5.8  -22.4±2.8* 
CS mid, %  -28.2±5.4  -24.5±4.6* 
CS apex, %  -26.2±8.9  -30.0±10.2 
LS basal, %  -20.8±4.4  -19.1±4.3 
LS mid, %  -13.1±4.6  -12.6±4.8 
LS apex, %  -15.0±4.0  -19.6±7.1 
3DS basal, %  36.9±13.5  34.7±13.9 
3DS mid, %  32.3±11.6  27.8±10.5 
3DS apex, %  17.1±6.5  17.7±12.2 
AS basal, %  -41.0±6.5  -37.0±5.3 
AS mid, %  -38.4±6.0  -34.7±6.2 
AS apex, %  -38.5±10.0  -44.4±13.0 
*

p<0.05 vs. controls.

3DS: three-dimensional strain; AS: area strain; CS: circumferential strain; LS: longitudinal strain; RS: radial strain.

In a recent study, higher probability of cardiac disease, LV systolic dysfunction, coronary artery disease/microvascular disease, and LV electrical remodeling were detected in patients with hemophilia A compared to matched controls.5 Moreover, impaired myocardial LV systolic function represented by increased myocardial performance index has also been demonstrated, related to arterial stiffness, in these patients.6 Although the number of hemophilia patients examined in the present study was small, significant reductions in 3DSTE-derived regional LV CSs were observed. No global, mean segmental or other regional LV strains differed between the groups examined. This finding appears to be important in the context of previous results including reduced apical LV rotation and twist in hemophilia.7 Regional LV deformation abnormalities in hemophilia could be explained by various factors including hemophilia-related increased aortic stiffness, altered blood quality, accompanying risk factors, and others.6 However, further studies are warranted to confirm these findings.

Conflicts of interest

The authors have no conflicts of interest to declare.

References
[1]
B. Zimmerman, L.A. Valentino.
Hemophilia: in review.
Pediatr Rev, 34 (2013), pp. 289-294
[2]
A. Nemes, A. Kalapos, P. Domsik, et al.
Three-dimensional speckle-tracking echocardiography – a further step in non-invasive three-dimensional cardiac imaging.
Orv Hetil, 153 (2012), pp. 1570-1577
[3]
A. Nemes, T. Forster.
Recent echocardiographic examination of the left ventricle – from M-mode to 3D speckle-tracking imaging.
Orv Hetil, 156 (2015), pp. 1723-1740
[4]
Á. Kormányos, P. Domsik, A. Kalapos, et al.
Active acromegaly is associated with enhanced left ventricular contractility: results from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path study.
Rev Port Cardiol, 39 (2020), pp. 189-196
[5]
Y. Zong, M. Maanja, R. Chaireti, et al.
Substantial prevalence of subclinical cardiovascular diseases in patients with hemophilia A evaluated by advanced electrocardiography.
J Electrocardiol, 58 (2020), pp. 171-175
[6]
Z.C. Özdemir, P. Köşger, B. Uçar, et al.
Myocardial functions, blood pressure changes, and arterial stiffness in children with severe hemophilia A.
Thromb Res, 189 (2020), pp. 102-107
[7]
A. Nemes, Á. Kormányos, P. Domsik, et al.
Left ventricular rotational abnormalities in hemophilia – insights from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study.
Quant Imaging Med Surg, 12 (2022), pp. 886-893
Copyright © 2022. Sociedade Portuguesa de Cardiologia
Baixar PDF
Idiomas
Revista Portuguesa de Cardiologia
Opções de artigo
Ferramentas
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Ao assinalar que é «Profissional de Saúde», declara conhecer e aceitar que a responsável pelo tratamento dos dados pessoais dos utilizadores da página de internet da Revista Portuguesa de Cardiologia (RPC), é esta entidade, com sede no Campo Grande, n.º 28, 13.º, 1700-093 Lisboa, com os telefones 217 970 685 e 217 817 630, fax 217 931 095 e com o endereço de correio eletrónico revista@spc.pt. Declaro para todos os fins, que assumo inteira responsabilidade pela veracidade e exatidão da afirmação aqui fornecida.